These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28167670)

  • 41. Crossed immunoelectrophoretic analysis of anti-Salmonella typhi antibodies in sera of typhoid patients and carriers: demonstration of the presence of typhoid-specific antibodies to a non-O, non-H, non-Vi antigen.
    Chau PY; Wan KC; Tsang RS
    Infect Immun; 1984 Mar; 43(3):1110-3. PubMed ID: 6199300
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Salmonella typhi O:9,12 polysaccharide-protein conjugates: characterization and immunoreactivity with pooled and individual normal human sera, sera from patients with paratyphoid A and B and typhoid fever, and animal sera.
    Aron L; Di Fabio J; Cabello FC
    J Clin Microbiol; 1993 Apr; 31(4):975-8. PubMed ID: 7681853
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Salmonella typhi: from a human pathogen to a vaccine vector.
    Zhang XL; Jeza VT; Pan Q
    Cell Mol Immunol; 2008 Apr; 5(2):91-7. PubMed ID: 18445338
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cloning and characterization of the gene encoding the z66 antigen of Salmonella enterica serovar Typhi.
    Huang X; Phung le V; Dejsirilert S; Tishyadhigama P; Li Y; Liu H; Hirose K; Kawamura Y; Ezaki T
    FEMS Microbiol Lett; 2004 May; 234(2):239-46. PubMed ID: 15135528
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new generation of stable, nonantibiotic, low-copy-number plasmids improves immune responses to foreign antigens in Salmonella enterica serovar Typhi live vectors.
    Galen JE; Wang JY; Chinchilla M; Vindurampulle C; Vogel JE; Levy H; Blackwelder WC; Pasetti MF; Levine MM
    Infect Immun; 2010 Jan; 78(1):337-47. PubMed ID: 19884333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antigenic analysis of Barber's protein antigen prepared from Salmonella typhi and demonstration of protein-specific antibodies in sera of typhoid patients.
    Tsang RS; Lui SW; Chau PY
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Apr; 254(2):244-52. PubMed ID: 6426195
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of an outer membrane protein of Salmonella enterica serovar typhimurium that confers protection against typhoid.
    Hamid N; Jain SK
    Clin Vaccine Immunol; 2008 Sep; 15(9):1461-71. PubMed ID: 18650399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Small alarmones (p)ppGpp regulate virulence associated traits and pathogenesis of Salmonella enterica serovar Typhi.
    Dasgupta S; Das S; Biswas A; Bhadra RK; Das S
    Cell Microbiol; 2019 Aug; 21(8):e13034. PubMed ID: 31013389
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Head-to-head comparison of humoral immune responses to Vi capsular polysaccharide and Salmonella Typhi Ty21a typhoid vaccines--a randomized trial.
    Kantele A; Pakkanen SH; Karttunen R; Kantele JM
    PLoS One; 2013; 8(4):e60583. PubMed ID: 23593253
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression, purification and evaluation of recombinant lipoprotein of Salmonella typhi as a vaccine candidate.
    Kumar A; Kundu S; Debnath Das M
    Biologicals; 2017 Mar; 46():108-113. PubMed ID: 28189484
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design of glycoconjugate vaccines against invasive African Salmonella enterica serovar Typhimurium.
    Rondini S; Micoli F; Lanzilao L; Gavini M; Alfini R; Brandt C; Clare S; Mastroeni P; Saul A; MacLennan CA
    Infect Immun; 2015 Mar; 83(3):996-1007. PubMed ID: 25547792
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Opsonizing antibodies in human typhoid fever.
    Vildé JL; Bouvet E
    J Clin Lab Immunol; 1980 Jul; 4(1):41-6. PubMed ID: 7463473
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunogenicity of Salmonella enterica serovar Enteritidis virulence protein, InvH, and cross-reactivity of its antisera with Salmonella strains.
    Dehghani B; Rasooli I; Gargari SL; Nadooshan MR; Owlia P; Nazarian S
    Microbiol Res; 2013 Feb; 168(2):84-90. PubMed ID: 23141708
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of Spleen-Induced Fimbria Production in Recombinant Attenuated
    Łaniewski P; Baek CH; Roland KL; Curtiss R
    mBio; 2017 Aug; 8(4):. PubMed ID: 28830946
    [No Abstract]   [Full Text] [Related]  

  • 55. Growth-phase regulation of lipopolysaccharide O-antigen chain length influences serum resistance in serovars of Salmonella.
    Bravo D; Silva C; Carter JA; Hoare A; Álvarez SA; Blondel CJ; Zaldívar M; Valvano MA; Contreras I
    J Med Microbiol; 2008 Aug; 57(Pt 8):938-946. PubMed ID: 18628492
    [TBL] [Abstract][Full Text] [Related]  

  • 56. M-01ZH09, an oral live attenuated Salmonella enterica serovar Typhi vaccine for the prevention of typhoid fever.
    Jain SK
    Curr Opin Mol Ther; 2009 Oct; 11(5):565-71. PubMed ID: 19806505
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpression, purification, and immunogenicity of recombinant porin proteins of Salmonella enterica serovar Typhi (S. Typhi).
    Kumar VS; Gautam V; Balakrishna K; Kumar S
    J Microbiol Biotechnol; 2009 Sep; 19(9):1034-40. PubMed ID: 19809263
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Core-linked LPS expression of Shigella dysenteriae serotype 1 O-antigen in live Salmonella Typhi vaccine vector Ty21a: preclinical evidence of immunogenicity and protection.
    Xu DQ; Cisar JO; Osorio M; Wai TT; Kopecko DJ
    Vaccine; 2007 Aug; 25(33):6167-75. PubMed ID: 17629369
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A mouse model for the human pathogen Salmonella typhi.
    Song J; Willinger T; Rongvaux A; Eynon EE; Stevens S; Manz MG; Flavell RA; Galán JE
    Cell Host Microbe; 2010 Oct; 8(4):369-76. PubMed ID: 20951970
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An adhesion protein of Salmonella enterica serovar Typhi is required for pathogenesis and potential target for vaccine development.
    Ghosh S; Chakraborty K; Nagaraja T; Basak S; Koley H; Dutta S; Mitra U; Das S
    Proc Natl Acad Sci U S A; 2011 Feb; 108(8):3348-53. PubMed ID: 21300870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.